IMMX
Immix Biopharma, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website immixbio.com
- Employees(FY) 9
- ISIN US45258H1068
Performance
+13.3%
1W
-3.89%
1M
-22.57%
3M
-44.49%
6M
-64.31%
YTD
+39.55%
1Y
Profile
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California.
Technical Analysis of IMMX 2024-05-10
Overview:
In analyzing the technical indicators for IMMX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide investme...
Recent News & Updates
- 2024-05-12 21:53
IMMX Stock Earnings: Immix Biopharma Beats EPS for Q1 2024(Investorplace)
- 2024-05-09 21:35
- 2024-04-29 02:50
- 2024-04-28 21:39
- 2024-04-17 21:37
- 2024-04-17 21:32
- 2024-04-14 21:36
- 2024-04-01 19:53
IMMX Stock Earnings: Immix Biopharma Misses EPS for Q4 2023(Investorplace)
- 2024-03-19 21:46
- 2024-03-04 20:35
- 2024-02-20 20:31
Immix Biopharma 12 Month Review Progress Update(Globenewswire)
- 2024-02-08 03:45
- 2024-02-06 20:37
- 2024-02-05 09:30
- 2024-02-05 02:20
- 2024-01-23 19:35
- 2024-01-03 20:34
- 2023-12-17 20:39
- 2023-12-10 20:36
- 2023-11-29 20:46
- 2023-11-27 19:50
- 2023-11-21 22:10
Immix (IMMX) CAR-T Therapy IND Cleared by FDA, Stock Down(Yahoo Finance)
- 2023-11-21 20:19
- 2023-11-20 20:46
- 2023-11-05 20:18
- 2023-11-05 20:12
- 2023-11-05 19:40
- 2023-10-30 21:55
- 2023-10-25 20:58
- 2023-10-15 21:05
Page 1 of 4
previousnext